Key result
Oral ondansetron fails to reduce ED vomiting vs placebo in children receiving ketamine sedation.
Why the study?
Does oral ondansetron reduce vomiting in children receiving intramuscular ketamine sedation?
RCT (n=63)
Double-blind
1:1 ratio, stratified by fasting duration
No
Does oral ondansetron reduce vomiting in children receiving intramuscular ketamine sedation?
Prophylactic oral ondansetron does not significantly reduce the incidence of vomiting in children receiving intramuscular ketamine for procedural sedation.
Answers are grounded in this paper and cite their sources.
Does not support routine ondansetron prophylaxis with IM ketamine sedation in children; confirms lack of antiemetic efficacy in this RCT.
Purpose: The purpose of this study is to investigate the effect of oral ondansetron on the incidence of vomiting in children who receive intramuscular (IM) ketamine for procedural sedation and analgesia in the emergency department (ED). Methods:In this double-blind, randomized, placebo-controlled trial in a children's hospital ED, patients receiving IM ketamine (5 mg/kg) for ED procedures were randomized to receive either oral ondansetron (2 mg or 4 mg) or placebo 15 minutes before the ketamine injection.We recorded whether vomiting occurred in the ED postsedation or up to 12 hours after discharge with telephone follow-up and compared ED length of stay and parental satisfaction.Results: Thirty two children were randomized to placebo and 31 to ondansetron.The groups were similar in age, sex, and fasting duration.ED vomiting was no significant difference with ondansetron: 7 of 31 (22.6%)versus 6 of 32 (18.8%),P=0.707, difference -3.8 (95% confidence interval -23.8% to 16.2%).Follow-up completed in 82.5%.The vomiting in the ED or after discharge in two groups, there was no significant difference: 7 of 27 (25.9%)versus 12 of 25 (48.0%),P=0.165, difference 22.1% (95% confidence interval -3.5% to 47.7%).ED length of stay and parental satisfaction were similar between groups. Conclusion:There is no significant reduction of the incidence of vomiting in oral ondansetron group with IM ketamine procedural sedation in children.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2014) conducted an RCT in Procedural sedation and analgesia (n=63). Oral ondansetron vs. Placebo was evaluated on Vomiting in the emergency department (difference -3.8%, 95% CI -23.8% to 16.2%, p=0.707). Oral ondansetron did not reduce the incidence of vomiting in the emergency department compared to placebo in children receiving intramuscular ketamine for procedural sedation.
Synapse has enriched 10 related papers. Consider them for comparative context: